Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its diagnosis and management are crucial tasks for emergency physicians. An important aspect of treating patients with AF is ...

Please provide your email address to receive an email when new articles are posted on . The strongest predictors of incident AF with a HR of 1.2 or greater were hypertension, older age, CAD, HF, ...

Female sex has a strong relationship with stroke risk in patients with nonvalvular A-fib, a new analysis affirms, but the disparity between women and men varies according to the presence of other risk ...

Please provide your email address to receive an email when new articles are posted on . For patients with atrial fibrillation, adding black ethnicity to CHA 2 DS 2-VASc score improves stroke ...

INTRODUCTION The CHA2DS2 -VASc and R2CHA2DS2-VASc scoring systems were designed to stratify thromboembolic risk in patients with atrial fibrillation. The R2CHA2DS2-VASc score, compared with the ...

Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; ...

A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.

Although patients with A-fib and those with atrial flutter (AFL) are generally managed by clinicians in much the same way for stroke prevention, new data suggest that a common risk score used for both ...

Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit. (HealthDay News) — Biomarkers of ischemic stroke risk are positively associated with ...

Dear Dr. Roach: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I've been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...

BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...